Behind the Scenes of Eli Lilly's Latest Options Trends
Behind the Scenes of Eli Lilly's Latest Options Trends
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with LLY, it often means somebody knows something is about to happen.Investors with a lot of money to spend have taken a bearish stance on Eli Lilly (NYSE:LLY).
有很多資金要投資的投資者對Eli Lilly (紐交所: LLY) 採取了看淡的態度。
And retail traders should know.
零售交易者應該知道。
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
我們在這裏追蹤的公開期權歷史記錄上看到交易時發現了這一點。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with LLY, it often means somebody knows something is about to happen.
無論這些機構是不是富有的個人，我們都不知道。但當有這樣大的事情發生在LLY身上，通常意味着有人知道即將發生的事情。
So how do we know what these investors just did?
那麼我們如何知道這些投資者剛剛做了什麼呢？
Today, Benzinga's options scanner spotted 45 uncommon options trades for Eli Lilly.
今天，Benzinga的期權掃描器發現了45筆Eli Lilly的非常規期權交易。
This isn't normal.
這不正常。
The overall sentiment of these big-money traders is split between 35% bullish and 40%, bearish.
這些大手交易者的整體情緒在35%看好和40%看淡之間分歧。
Out of all of the special options we uncovered, 16 are puts, for a total amount of $787,657, and 29 are calls, for a total amount of $1,433,279.
在我們發現的所有特殊期權中，有16個看跌期權，總金額爲$787,657，有29個看漲期權，總金額爲$1,433,279。
What's The Price Target?
目標價是多少？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $440.0 to $1340.0 for Eli Lilly during the past quarter.
分析這些合約的成交量和未平倉量，似乎大戶在過去一個季度一直密切關注艾禮禮，價格範圍從$440.0到$1340.0。
Insights into Volume & Open Interest
成交量和持倉量分析
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Eli Lilly's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Eli Lilly's substantial trades, within a strike price spectrum from $440.0 to $1340.0 over the preceding 30 days.
評估成交量和未平倉量是期權交易中的戰略步驟。這些指標揭示了對艾禮禮期權在指定行權價格上的流動性和投資者興趣。即將公佈的數據可視化展示了過去30天內艾禮禮看漲和看跌期權的成交量和未平倉量波動，涵蓋了從$440.0到$1340.0的行權價範圍內的大宗交易。
Eli Lilly Option Activity Analysis: Last 30 Days
Eli Lilly期權活動分析：最近30天
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BEARISH | 01/17/25 | $75.3 | $72.6 | $73.0 | $900.00 | $182.5K | 1.9K | 5 |
| LLY | PUT | SWEEP | BULLISH | 10/25/24 | $7.65 | $7.6 | $7.6 | $900.00 | $152.0K | 636 | 4 |
| LLY | PUT | TRADE | BULLISH | 02/21/25 | $28.25 | $25.7 | $25.9 | $800.00 | $129.5K | 231 | 57 |
| LLY | CALL | SWEEP | BEARISH | 12/20/24 | $56.05 | $54.25 | $54.25 | $910.00 | $81.3K | 144 | 15 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $154.85 | $151.6 | $153.63 | $780.00 | $76.8K | 3.2K | 10 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看漲 | 交易 | 看淡 | 01/17/25 | $75.3 | $72.6 | $73.0 | $900.00 | $182.5K | 1.9K | 5 |
| LLY | 看跌 | SWEEP | 看好 | 10/25/24 | $7.65 | $7.6 | $7.6 | $900.00 | $152.0K | 636 | 4 |
| LLY | 看跌 | 交易 | 看好 | 02/21/25 | $28.25 | $25.7 | $25.9 | $800.00 | $129.5K | 231 | 57 |
| LLY | 看漲 | SWEEP | 看淡 | 12/20/24 | $56.05 | $54.25 | $54.25 | $910.00 | $81.3K | 144 | 15 |
| LLY | 看漲 | 交易 | 看好 | 01/17/25 | $154.85 | $151.6 | $153.63 | $780.00 | $76.8K | 3.2K | 10 |
About Eli Lilly
關於Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly是一家專注於神經科學，心臟代謝，癌症和免疫學的藥物公司。Lilly的主要產品包括用於治療癌症的Verzenio；用於心臟代謝的Mounjaro，Zepbound，Jardiance，Trulicity，Humalog和Humulin；以及用於免疫學的Taltz和Olumiant。
Where Is Eli Lilly Standing Right Now?
Eli Lilly目前處於什麼位置？
- With a volume of 838,270, the price of LLY is down -0.08% at $916.36.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 12 days.
- LLY的成交量爲838,270，價格下跌-0.08%，爲916.36美元。
- RSI指標暗示該標的股票目前處於超買和超賣的中立區間。
- 下一次公佈的收益預計將在12天后發行。
Expert Opinions on Eli Lilly
關於Eli Lilly的專家意見
In the last month, 3 experts released ratings on this stock with an average target price of $1052.6666666666667.
在過去一個月裏，3位專家發佈了對這隻股票的評級，平均目標價爲1052.6666666666667美元。
Turn $1000 into $1270 in just 20 days?
在短短20天內，將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* In a cautious move, an analyst from Bernstein downgraded its rating to Outperform, setting a price target of $1100. * Reflecting concerns, an analyst from Deutsche Bank lowers its rating to Buy with a new price target of $1025.* Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Eli Lilly, targeting a price of $1033.
20年期權交易老手揭示了他的一行圖表技術，顯示何時買入和賣出。複製他的交易，平均每20天獲利27%。點擊這裏獲取訪問權限。* 作爲謹慎舉措，來自伯恩斯坦的分析師將其評級下調至強於市場，設定價格目標爲1100美元。* 反映擔憂，德意志銀行的分析師將其評級降級至買入，設定新目標價爲1025美元。* 保持立場，Truist Securities的分析師繼續持有對Eli Lilly的買入評級，目標價爲1033美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。
